CLSD Oct 2024 7.500 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:26AM EDT. Market open.
Loading interactive chart...
- Simply Wall St.
Shareholders in Clearside Biomedical (NASDAQ:CLSD) are in the red if they invested three years ago
If you love investing in stocks you're bound to buy some losers. But the last three years have been particularly tough...
- GlobeNewswire
Clearside Biomedical Announces Publication of Consensus Guidelines for Drug Delivery via Suprachoroidal Space (SCS®) Injection in Leading Peer-Reviewed Industry Journal, RETINA®
- Expert Panel of Ophthalmologists Developed Professional Guidelines in Using the Innovative Technique for Retinal Therapeutic Delivery - - Current Clinical Evidence and Physician Experience Support SCS Injection as a Safe and Effective Method for Delivering Retinal and Choroidal Therapeutics - ALPHARETTA, Ga., May 21, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprac
- Thomson Reuters StreetEvents
Q1 2024 Clearside Biomedical Inc Earnings Call
Q1 2024 Clearside Biomedical Inc Earnings Call
© 2024 Yahoo. All rights reserved.